Author:
Junior J. Ribamar Costa,Sousa Amanda G.M.R.,Moreira Adriana Costa,da Costa Ricardo A.,Maldonado Galo,Cano Manuel N.,Neto Cantídio Campos,Sousa J. Eduardo
Reference28 articles.
1. Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial
2. Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice;Amin,2012
3. Health economic evaluation of the use of drug-eluting stents: first results from the Drug-Eluting Stent Registry (DES.de). Herz;Willich,2012
4. Uso do escore de propensão na análise de custo-efetividade com utilização seletiva de stents farmacológicos e não-farmacológicos;Ferreira;Rev Bras Cardiol Invasiva,2012
5. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group;Serruys;N Engl J Med.,1994